loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for Doxazosin Mesylate? Find Parenteral used in Doxazosin Mesylate to address drug delivery challenges on PharmaCompass.

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    View Presentation

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Menu

    Doxazosin Mesylate

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,075Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2Seqens

    02 1Nanjing Well Pharmaceutical

    03 2Actylis

    04 3Pluviaendo

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    01

    Seqens

    France
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Dosage Form : Injectable / Parenteral

    Grade : Parenteral

    Brand Name : Expansorb® PLA / PEG

    Application : Parenteral

    Excipient Details : Expansorb® PLA?/PEG? polymers are used as functional excipients in injectable formulations for controlled & slow drug release with a single injection.

    Pharmacopoeia Ref : N/A

    Technical Specs : Classic and ultrapure LMP

    Ingredient(s) : Poly lactic acid, Polyethylene Glycol Excipient

    Dosage Form : Injectable / Parenteral

    Grade : Parenteral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Ingredient(s) : Poly lactic acid, Polyethylene Glycol Excipient

    Dosage Form : Injectable / Parenteral

    Category : Parenteral

    Brand : EXPANSORB® PLA / PEG

    Applications : Expansorb® PLA?/PEG? polymers are used as functional excipients in injectable formulations for controlled & slow drug release with a single injection.

    Pharmacopoeia Ref : N/A

    Technical Specs : Classic and ultrapure LMP

    Grade : Parenteral

    arrow
    Expansorb® PLA / PEG

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    02

    Nanjing Well Pharmaceutical

    China
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Dosage Form : Injectable / Parenteral

    Grade : Parenteral

    Brand Name : Lactose Monohydrate

    Application : Parenteral

    Excipient Details : Lactose monohydrate is used as a diluent in inhalation and lyophilized preparations.

    Pharmacopoeia Ref : ChP/USP/EP/JP

    Technical Specs : NA

    Ingredient(s) : Lactose Monohydrate

    Dosage Form : Injectable / Parenteral

    Grade : Parenteral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Ingredient(s) : Lactose Monohydrate

    Dosage Form : Injectable / Parenteral

    Category : Parenteral

    Brand : LACTOSE MONOHYDRATE

    Applications : Lactose monohydrate is used as a diluent in inhalation and lyophilized preparations.

    Pharmacopoeia Ref : ChP/USP/EP/JP

    Technical Specs : NA

    Grade : Parenteral

    arrow
    Nanjing Well Lactose Monohydrate

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    03

    Seqens

    France
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Dosage Form : Injectable / Parenteral

    Grade : Parenteral

    Brand Name : Expansorb® PLGA / PEG

    Application : Parenteral

    Excipient Details : Expansorb® PLGA? / PEG copolymers are used as functional excipients in single dose injections for controlled and slow drug release (weeks to months).

    Pharmacopoeia Ref : N/A

    Technical Specs : Classic and ultrapure LMP

    Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid, Polyethylene Glycol Excipient

    Dosage Form : Injectable / Parenteral

    Grade : Parenteral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid, Polyethylene Glycol Excipient

    Dosage Form : Injectable / Parenteral

    Category : Parenteral

    Brand : EXPANSORB® PLGA / PEG

    Applications : Expansorb® PLGA? / PEG copolymers are used as functional excipients in single dose injections for controlled and slow drug release (weeks to months).

    Pharmacopoeia Ref : N/A

    Technical Specs : Classic and ultrapure LMP

    Grade : Parenteral

    arrow
    Expansorb® PLGA / PEG

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    04

    Pluviaendo

    LACTOSE MONOHYDRATE

    arrow
    2024 ACI Convention
    Not Confirmed

    Pluviaendo

    Turkey
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule, Injectable / Parenteral, Tablet

    Grade : Oral, Parenteral

    Brand Name : Lactose Monohydrate

    Application : Fillers, Diluents & Binders, Parenteral

    Excipient Details : Lactose Monohydrate is widely used as a filler and diluent in tablets and capsules and in the production of lyophilized and parenteral products.

    Pharmacopoeia Ref : N/A

    Technical Specs : N/A

    Ingredient(s) : Lactose Monohydrate

    Dosage Form : Capsule, Injectable / Parenteral, Tablet

    Grade : Oral, Parenteral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Lactose Monohydrate

    Dosage Form : Capsule, Injectable / Parenteral, Tablet

    Category : Fillers, Diluents & Binders, Parenteral

    Brand : LACTOSE MONOHYDRATE

    Applications : Lactose Monohydrate is widely used as a filler and diluent in tablets and capsules and in the production of lyophilized and parenteral products.

    Pharmacopoeia Ref : N/A

    Technical Specs : N/A

    Grade : Oral, Parenteral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    05

    Actylis

    SODIUM CHLORIDE USP

    arrow
    2024 ACI Convention
    Not Confirmed

    06

    Actylis

    NACL MULTI-COMPENDIAL LOW ENDOTOXIN

    arrow
    2024 ACI Convention
    Not Confirmed